Early Testing for Alzheimer’s: The Alzheimer’s LINX with Chase Zittrauer from Cyrex Labs
About this episode
The episode discusses early testing for Alzheimer's disease with a focus on the Alzheimer's LINX panel and its implications for brain health.
In this 169th episode, I speak with Chase Zittrauer, my rep for Cyrex Labs. We spent some time diving into one of the fastest-growing health crises of our time — Alzheimer’s and related dementias — and what cutting‑edge testing can reveal long before symptoms show up. We unpack the rising global and U.S. burden ofAlzheimer’s: the financial, emotional, and caregiving toll it takes on families. Then we’ll explore a provocative link many clinicians are watching — how COVID-19, long COVID, and immune dysregulation might influence brain health. We discuss a unique laboratory testing approach from Cyrex Labs - The Alzheimer's LINX panel - that looks for early immune signals of brain stress — antibodies to key brain proteins like amyloid beta and tau, as well as cross‑reactivity with pathogens, chemicals, and foods. We’ll explain why plaques and tangles aren’t the wholestory, why single‑target drugs fall short, and how lifestyle andmetabolic factors — think insulin and blood sugar — matter in prevention. Chase shares his own test results and what they revealed about pathogens, phthalates, and food triggers. We also cover the blood‑brain barrier, aluminum and other chemical neoantigens…
More episodes of A Functional Approach with Dr. Jim Chialtas
- Are you living with Mold? A frank conversation with Jason Earl from "Got Mold?"
- Epitalon: The wellness and longevity peptide!
- Thymulin-Zinc: Rebalancing Immunity with Age
- To Treat or Not to Treat: Infections in Autoimmunity
- The DNF-10 Peptide: A safe and effective pick for weight loss support
Explore listener stats, chart rankings, contacts and more on the A Functional Approach with Dr. Jim Chialtas podcast page.